Immunic AG | WebDisclosure

Basculer en Français

10866	Companies
236216	Keywords
165133	Articles
126667	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 09/09/2025 at 12:30, 11 months 12 days ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic receives United States Patent Notice of Allowance for Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis, extending protection into 2041

United States Patent Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Patent Notice Of Allowance
BRIEF

published on 09/04/2025 at 12:35, 11 months 17 days ago

Immunic annonce sa participation à des conférences clés

Réunions D'investisseurs Immunique Vidofludimus Calcique ECTRIMS 2025 Conférence Biopharmaceutique
BRIEF

published on 09/04/2025 at 12:35, 11 months 17 days ago

Immunic Announces Participation in Key Conferences

Immunic Vidofludimus Calcium Investor Meetings Biopharma Conference ECTRIMS 2025
PRESS RELEASE

published on 09/04/2025 at 12:30, 11 months 17 days ago

Immunic to Participate in Investor and Scientific Conferences in September
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in September, including H.C. Wainwright 27th Annual Global Investment Conference and ECTRIMS Congress

Investor Conference Clinical Pipeline Scientific Conference Immunic Inc ECTRIMS Congress
BRIEF

published on 08/07/2025 at 12:35, 1 year ago

Immunic publie ses résultats financiers du deuxième trimestre 2025 avec les progrès du Vidofludimus Calcium

Essais Sur La Sclérose En Plaques Dépenses De R&D Vidofludimus Calcique Résultats Financiers D'Immunic Investissement Dans Les Biotechnologies
BRIEF

published on 08/07/2025 at 12:35, 1 year ago

Immunic Reports Q2 2025 Financial Results with Vidofludimus Calcium Progress

Vidofludimus Calcium Multiple Sclerosis Trials R&D Expenses Biotech Investment Immunic Financial Results
PRESS RELEASE

published on 08/07/2025 at 12:30, 1 year ago

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports positive Q2 2025 results with focus on clinical progress of vidofludimus calcium for multiple sclerosis treatment

Clinical Trials Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Q2 2025 Results
BRIEF

published on 06/24/2025 at 12:35, 1 year 1 month ago

Immunic Releases Promising Long-Term Data on Vidofludimus Calcium for MS

Multiple Sclerosis Vidofludimus Calcium Phase 2 Trial Long-Term Data Neurological Function
BRIEF

published on 06/24/2025 at 12:35, 1 year 1 month ago

Immunic publie des données prometteuses à long terme sur le vidofludimus calcique pour la sclérose en plaques

Sclérose En Plaques Essai De Phase 2 Vidofludimus Calcique Données À Long Terme Fonction Neurologique
PRESS RELEASE

published on 06/24/2025 at 12:30, 1 year 1 month ago

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Immunic reports positive long-term data from phase 2 EMPhASIS Trial of Vidofludimus Calcium in relapsing-remitting multiple sclerosis, showing favorable safety & tolerability profile up to 5.5 years

Multiple Sclerosis Immunic Vidofludimus Calcium Safety EMPhASIS Trial

Accesswire

Published on 08/21/2026 at 13:30, 4 hours 6 minutes ago

BULGOLD Announces Filing Of Financial Results For the Six Months Ended June 30, 2026
Published on 08/21/2026 at 02:30, 15 hours 6 minutes ago

PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 17 hours 36 minutes ago

Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 18 hours 36 minutes ago

EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 19 hours 36 minutes ago

Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M

View all ACCESSWIRE

EQS Group

Published on 08/21/2026 at 17:27, 9 minutes ago

EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 hour 6 minutes ago

BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/21/2026 at 15:23, 2 hours 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 08/21/2026 at 15:22, 2 hours 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/21/2026 at 15:21, 2 hours 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Les Echos

Published on 08/21/2026 at 08:30, 9 hours 6 minutes ago

Thales issues a €1bn bond
Published on 08/21/2026 at 08:30, 9 hours 6 minutes ago

Thales émet un emprunt obligataire de 1 Md€
Published on 08/18/2026 at 18:00, 2 days 23 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 23 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 3 days 6 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026

View all LES ECHOS COMFI WIRE